Clinical Trial

Efficacy Heterogeneity of Lactobacillus Paracasei LC19 on Type 2 Diabetes

Name: Efficacy Heterogeneity of Lactobacillus Paracasei LC19 on Type 2 Diabetes — clinical trial record (NCT07520305)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This is a single-arm study to investigate the heterogeneity of glycemic response to Lactobacillus paracasei LC19 in patients with newly diagnosed type 2 diabetes. Participants will receive LC19 for 12 weeks, and changes in glycemic control will be evaluated.

Trial Details

NCT Number	NCT07520305
Lead Sponsor	Beijing Chao Yang Hospital
Conditions	Type 2 Diabetes
Enrollment	70 participants
Start Date	2026-04-20
Primary Completion	2027-12-31 (estimated)
Study Completion	2028-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-09